Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company formed to pursue a merger or acquisition target within the biotechnology and life sciences sector. The SPAC filed an 8-K with the SEC on June 13, 2022, accession number 0001213900-22-032368, reflecting a material corporate event during its search period. Focused on the biotech vertical, BIOT joins a competitive cohort of life-sciences-oriented SPACs that accelerated through the market during the 2021–2022 SPAC wave. Sponsor details were not disclosed in the available filing metadata. Investors and analysts tracking BIOT's deal pipeline and corporate filings can access the full dossier, including SEC submission history and status updates, by signing up for SpacDesk at spacdesk.com.